Who makes BMEC-1217B?

BMEC-1217B is developed by Medigreen Biotechnology Corp..

Last reviewed 2026-04-19 · How we verify

BMEC-1217B

Medigreen Biotechnology Corp. · Phase 1 active Small molecule

At a glance

Generic name	BMEC-1217B
Sponsor	Medigreen Biotechnology Corp.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BMEC-1217B CI brief — competitive landscape report
BMEC-1217B updates RSS · CI watch RSS
Medigreen Biotechnology Corp. portfolio CI